Review of Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin

Pre-publication Review of

Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin

Reviewed On February 01, 2022

Verified

Submitted to

Reviewed by

Actions

Reviewed on February 01, 2022

Source

References

Sheng-Yao, C., H., W. A. T., El-Saber, B. G., Ching-Liang, H., Jih-Chin, L., Yusuf, L. H., Mohammed, A., N., A. A., Jia-Hong, C. 2022. Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin. Biology.